Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by AE Harrington
Cost-Effectiveness of Edoxaban Compared With Other Licensed Noacs for the Prevention of Stroke and Systemic Embolic Events in the Uk
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Pcv80 - Cost-Effectiveness of Noacs in Prevention of Stroke and Systemic Embolism in the Czech Republic
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Cost-Effectiveness of Dabigatran Etexilate Compared With Edoxaban in the Treatment of Acute Venous Thromboembolism in the Uk
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Cost-Effectiveness of New Oral Anticoagulants Compared With Warfarin in Preventing Stroke and Other Cardiovascular Events in Patients With Atrial Fibrillation
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcv84 - Cost-Effectiveness Analysis of Apixaban Versus Edoxaban for Stroke Prevention in Non-Valvular Atrial Fibrillation Spanish Patients
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Potential Role of Edoxaban in Stroke Prevention Guidelines
Arrhythmia and Electrophysiology Review
Cardiovascular Medicine
Physiology
Cardiology
Cost-Effectiveness of Apixaban Compared With Aspirin for Stroke Prevention in Atrial Fibrillation Among Patients Unsuitable for Warfarin
Circulation. Cardiovascular quality and outcomes
Medicine
Cardiovascular Medicine
Cardiology
Estimating the Cost-Effectiveness of Stroke Units in France Compared With Conventional Care
Stroke
Cardiology
Neurology
Cardiovascular Medicine
Advanced
Medicine
Neuroscience
Specialized Nursing
NAVIGATE ESUS: Phase-Iii RCT Assessing Prevention of Stroke and Systemic Embolism in Patients With Embolic Stroke of Undetermined Source
Journal of the Neurological Sciences
Neurology
Pcv53 - Is Edoxaban More Cost-Effective Than Warfarin in Prevention of Stroke and Deep Vein Thrombosis?
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental